A Study of GC3107(BCG Vaccine) in Healthy Infants

NCT03947138 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

BCG Vaccination Reaction
Tuberculosis

Interventions

BIOLOGICAL: GC3107
BIOLOGICAL: Intradermal BCG SSI inj.

Sponsor

Green Cross Corporation